Navigation Links
Mission Pharmacal Celebrates Historic Milestone
Date:2/2/2009

Pioneer in Women's Health Marks 64 Years of Innovation and Growth

SAN ANTONIO, Feb. 2 /PRNewswire/ -- Mission Pharmacal Company this year celebrates 64 years of excellence in manufacturing and distributing pharmaceutical products primarily for women's health. For more than six decades, Mission Pharmacal has enhanced the quality of consumers' lives through innovative, science-based, quality pharmaceutical products, vitamins and supplements.

Founded in 1945 by H.N. Walsdorf, a pharmacist, the Texas-based company was built on the philosophy that most existing pharmaceutical formulations had the potential to be more effective and better tolerated. Three generations later, Neill B. Walsdorf, Jr. carries on the traditions of quality and value established by his grandfather and continued by his father.

"We are honored to celebrate 64 years in the pharmaceutical industry," said Neill Walsdorf, Jr., president of Mission Pharmacal. "We recognize this achievement and will continue my grandfather's mission to provide breakthrough products and the level of quality that has been associated with the Mission name. In addition to our expertise in current therapeutic areas, we will look to developments in new areas of osteoporosis, urolithiasis and cardiovascular disease."

The company has a broad portfolio of over-the-counter and prescription products that enhance prenatal nutrition, treat parasitic and bacterial infections, prevent kidney stone recurrence and help relieve arthritis and muscle pain. Major brands include the CitraNatal(R) family of prescription prenatal vitamins, designed to support pregnant women's comfort with calcium citrate and other well-tolerated ingredients while optimizing nutrition for their babies' growth and development; Ferralet(R) 90, for iron deficiency anemia, that transforms prescription oral iron therapy into a gentle experience with carbonyl iron; Tindamax(R) (tinidazole), the only oral antimicrobial approved for the treatment of both trichomoniasis and bacterial vaginosis (as well as many other bacterial infections) and Urocit-K(R), a formulation of potassium citrate used to treat nephrolithiasis in people with kidney stones that is the standard treatment in its category.

About Mission Pharmacal Company

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas. For more than 60 years, Mission has been committed to meeting the unique needs of women throughout all stages of life, identifying unmet health needs in the marketplace, and developing innovative prescription and over-the-counter products to meet them. Currently, Mission Pharmacal provides physicians and consumers with pharmaceutical and nutritional products. For more information on Mission, visit www.missionpharmacal.com.


'/>"/>
SOURCE Mission Pharmacal Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
2. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
3. Sierra Tucson Achieves Hospital Accreditation, Now Holds Dual Accreditation by the Joint Commission
4. Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohns Disease
5. Fairview Baptist Home Selects PatientPlacement.com to Automate Referrals and Increase Patient and Resident Admissions
6. EliteMeetings.com Announces Commission-Free Policy Comprehensive Search and RFP Engine Now Provides Net Rates for Groups
7. In Time, Cream Might Prevent Herpes Transmission
8. Pennsylvania Insurance Commissioner Welcomes U.S. House Vote to Reauthorize Childrens Health Care
9. One Mans Determined Journey to Remission and a Renewed Sense of Faith
10. Particulate Emission from Natural Gas Burning Home Appliances Is Assessed in Environmental Engineering Science Journal
11. Kansas Insurance Commissioner, Sandy Praeger, to Appear this Saturday on Cary Hall's Health Insurance Advocate Radio Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest ... . , Millions of individuals in the United States and Canada wear eyeglasses. Once ... to both correct vision and make a fashion statement. Even celebrities use glasses as ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: